Skip to main content

Table 3 Prevalence of selected human papillomavirus (HPV) types and groups of HPV types among HPV-positive women, by cervical status

From: Human papillomavirus infection in Bhutan at the moment of implementation of a national HPV vaccination programme

HPV type

Normala

CIN3b

Cancerb

Cancer: normal cytology

 

(N = 2272)

(N = 211)

(N = 112)

Prevalence ratio (95% CI)

 

n

(% of HPV pos)

n

(% of HPV pos)

n

(% of HPV pos)

 

Any

522

-

183

-

99

-

-

16

78

(15)

109

(60)

62

(63)

5.8 (4.0-8.3)

18

53

(10)

4

(2)

7

(7)

0.7 (0.4-1.5)

16/18

127

(24)

113

(62)

69

(70)

5.0 (3.4-7.4)

31

21

(4)

14

(8)

4

(4)

1.0 (0.4-2.5)

33

21

(4)

12

(7)

2

(2)

0.5 (0.1-2.0)

45

28

(5)

2

(1)

5

(5)

0.9 (0.4-2.2)

52

28

(5)

2

(1)

3

(3)

0.6 (0.2-1.8)

58

27

(5)

32

(18)

5

(5)

1.0 (0.4-2.2)

16/18/31/33/45/52/58

235

(45)

168

(92)

87

(88)

6.7 (3.8-12.1)

Other high-risk types

104

(20)

11

(6)

9

(9)

0.4 (0.2-0.8)

Possible high-risk types

98

(19)

4

(2)

4

(4)

0.2 (0.1-0.6)

Low-risk types

214

(41)

8

(4)

5

(5)

0.1 (0.0-0.2)

Multiple infections

164

(31)

16

(9)

6

(6)

0.2 (0.1-0.4)

  1. aHPV tested in cervical cells from women diagnosed with normal cytology from general population survey.
  2. bHPV tested in biopsies from women diagnosed with histologically confirmed CIN3 and ICC from case series.